VYNE Therapeutics (VYNE)
(Delayed Data from NSDQ)
$2.50 USD
+0.03 (1.21%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $2.51 +0.01 (0.40%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth F Momentum F VGM
Earnings News For VYNE
-
VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update
-
VYNE Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
-
VYNE Therapeutics Inc. (VYNE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
VYNE Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
-
VYNE Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
-
VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates
-
VYNE Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
-
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Misses Revenue Estimates
-
VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates
-
VYNE Therapeutics Inc. (VYNE) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Lags Revenue Estimates
-
VYNE Therapeutics Inc. (VYNE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates
-
VYNE Therapeutics Inc. (VYNE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates
-
VYNE Therapeutics Inc. (VYNE) Reports Q4 Loss, Misses Revenue Estimates